Papers/PMID:33053149
Selenium, antioxidants, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.
The American journal of clinical nutrition2020The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
selenium atom — no detected effect on all-cause mortality
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull resultreplicated ×3“Selenium taken alone (Supplementary Figures 4–15) and combined antioxidants (Supplementary Figures 16–27) were not associated with CVD outcomes, CVD mortality, cancer, cancer mortality, or all-cause mortality.”
Quoted verbatim from Selenium, antioxidants, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Adults in randomised trials of oral selenium supplementation alone versus placebo, at least 24 weeks; pooled across trials with follow-up as each trial reported
Selenium, antioxidants, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.2020PMID:33053149Industry fundedPermalink